The DNA-testing firm 23andMe has seen its share price fall by more than 70 percent this year and was reported as 'fighting for its survival' in a BBC news article.
Now, the BBC report that 23andMe will cut 40 percent of its workforce. The job cuts are expected to lead to one-off costs of $12m, including severance pay, for the plan that will result in savings of $35m.
